Poland is regarded as one of the largest clinical trials markets in CEE/CIS. In a report in 2010, PriceWaterHouseCoopers (PwC) pointed that with 469 new clinical trials registrations in 2009, Poland accounted for c. 2.5%-3.0% of the world market by registration volumes. Current Status of Clinical Research in Poland Status of clinical research has degraded over […]

Read More →

Identification and selection of clinical sites and investigator remains one of the first and most important decisions that trial managers take. This also happens to be the one that may define the success (or, failure) of the project. We had been seeing the impact of site / investigator identification on clinical trial successes time and […]

Read More →

The United States has consistently emerged as a leading site for clinical research. Clinicaltrials.gov registry, which serves as an effective reference to see clinical trials conducted worldwide, provides an interesting statistics regarding U.S. clinical trials. Clinical trials statistics in the U.S. A glimpse into the studies registered between 2011 and 2013 and further between 2014 […]

Read More →